VBI Vaccines Inc.
NASDAQ:VBIV
0.0653 (USD) • At close August 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 8.682 | 1.082 | 0.631 | 1.061 | 2.221 | 3.355 | 0.865 | 0.548 | 0.955 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0 | 0.069 | 0.066 | 0.07 | 0.072 |
Cost of Revenue
| 14.497 | 11.276 | 10.77 | 9.168 | 7.904 | 4.509 | 5.193 | 3.671 | 3.755 | 0 | 4.637 | 10.817 | 0 | 0 | 0 | 0.009 | 0.013 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| -5.815 | -10.194 | -10.139 | -8.107 | -5.683 | -1.154 | -4.328 | -3.123 | -2.8 | 0 | -4.637 | -10.817 | 0 | 0 | 0 | -0.009 | -0.013 | 0 | 0 | 0 | 0 | 0.001 | 0 | 0.069 | 0.066 | 0.07 | 0.072 |
Gross Profit Ratio
| -0.67 | -9.421 | -16.068 | -7.641 | -2.559 | -0.344 | -5.003 | -5.699 | -2.932 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Reseach & Development Expenses
| 9.343 | 15.506 | 19.558 | 14.859 | 26.332 | 38.467 | 20.918 | 9.966 | 0.618 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 42.143 | 56.12 | 38.335 | 20.651 | 14.092 | 20.787 | 12.034 | 11.761 | 6.683 | 1.418 | 2.412 | 2.533 | 17.559 | 0.732 | 0.326 | 0.593 | 0.429 | 0.454 | 0 | 0 | 0 | 0.071 | 0.086 | 0.069 | 0.133 | 0.141 | 0.145 |
Selling & Marketing Expenses
| -1.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.25 | 0.118 | 0.127 | 0 | -0.026 | -0.07 | -0.065 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 40.153 | 56.12 | 38.335 | 20.651 | 14.092 | 20.787 | 12.034 | 11.761 | 6.683 | 1.418 | 2.412 | 2.783 | 17.559 | 0.732 | 0.326 | 0.567 | 0.359 | 0.389 | 0.13 | 0.132 | 0.082 | 0.071 | 0.086 | 0.069 | 0.133 | 0.141 | 0.145 |
Other Expenses
| 24.6 | 0 | 0 | 20.651 | 20.384 | 20.787 | 12.034 | 11.761 | 0.862 | 3.872 | 4.967 | 0.012 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 49.496 | 71.626 | 57.893 | 35.51 | 40.424 | 59.254 | 32.952 | 21.727 | 8.163 | 5.29 | 7.38 | 2.795 | 17.559 | 0.732 | 0.326 | 0.567 | 0.359 | 0.389 | 0.13 | 0.132 | 0.082 | 0.071 | 0.086 | 0.069 | 0.133 | 0.141 | 0.145 |
Operating Income
| -55.311 | -81.82 | -68.032 | -43.617 | -52.399 | -60.408 | -37.28 | -24.85 | -8.836 | -5.148 | -7.119 | -13.767 | -17.559 | -0.732 | -0.258 | -0.576 | -0.368 | -0.35 | -0.135 | -0.137 | -0.089 | -0.563 | -0.19 | -0.069 | -0.133 | -0.282 | -0.217 |
Operating Income Ratio
| -6.371 | -75.619 | -107.816 | -41.109 | -23.593 | -18.005 | -43.098 | -45.347 | -9.252 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,728.163 | -179.316 | -1,107.882 | -300,076.89 | -1 | -2 | -4 | -3 |
Total Other Income Expenses Net
| -37.525 | -31.483 | -1.721 | -2.613 | -2.414 | -0.56 | 0.736 | 0.189 | -2.816 | 0.144 | 0.261 | -0.155 | -1.337 | 0.014 | -0.014 | 0.006 | -0.005 | 0.036 | -0.006 | -0.005 | -0.008 | -0.493 | -0.105 | 0 | -0.066 | -0.211 | -0.072 |
Income Before Tax
| -92.836 | -113.303 | -69.753 | -46.23 | -54.813 | -63.6 | -39.426 | -24.985 | -14.884 | -4.594 | -6.653 | -13.155 | -18.896 | -0.717 | -0.331 | -0.558 | -0.365 | -0.314 | -0.135 | -0.137 | -0.097 | -0.07 | -0.295 | 0 | -0.199 | -0.493 | -0.29 |
Income Before Tax Ratio
| -10.693 | -104.716 | -110.544 | -43.572 | -24.679 | -18.957 | -45.579 | -45.593 | -15.585 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,728.163 | -196.313 | -138.535 | -465,169.829 | 0 | -3 | -7 | -4 |
Income Tax Expense
| 1.822 | 27.648 | 2.897 | 1.056 | 0.992 | 0.56 | -0.431 | -1.78 | -0.129 | -0.84 | -0.987 | -0.303 | 2.631 | -0.028 | 0.015 | -0.024 | -0.159 | -0.082 | -0.084 | 0.01 | 0.017 | 0.986 | -0.003 | 0.069 | 0.066 | 0.07 | -0.072 |
Net Income
| -92.836 | -140.951 | -72.65 | -47.286 | -55.805 | -63.6 | -38.995 | -23.205 | -14.755 | -4.594 | -6.653 | -13.155 | -18.853 | -0.717 | -0.331 | -0.558 | -0.205 | -0.343 | -0.051 | -0.137 | -0.09 | -0.563 | -0.188 | -0.069 | -0.199 | -0.352 | -0.217 |
Net Income Ratio
| -10.693 | -130.269 | -115.135 | -44.567 | -25.126 | -18.957 | -45.081 | -42.345 | -15.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,728.163 | -182.019 | -1,107.882 | -295,773.891 | -1 | -3 | -5 | -3 |
EPS
| -5.96 | -16.37 | -8.55 | -6.5 | -14.02 | -29.06 | -26.49 | -23.17 | -35.05 | -21.27 | -32.73 | -66.64 | -287.5 | -15.27 | -8.75 | -15.36 | -6.53 | -15.87 | -2.82 | -9.1 | -8.18 | -45.14 | -15.23 | -8.26 | -23.86 | -33.81 | -26.09 |
EPS Diluted
| -5.96 | -16.37 | -8.55 | -6.5 | -14.02 | -29.06 | -26.49 | -23.17 | -35.05 | -21.27 | -32.73 | -66.64 | -287.5 | -15.27 | -8.75 | -15.36 | -6.53 | -15.87 | -2.82 | -9.1 | -8.18 | -45.14 | -14.25 | -8.26 | -23.86 | -33.81 | -26.09 |
EBITDA
| -53.321 | -81.82 | -68.032 | -43.617 | -46.107 | -59.244 | -36.55 | -24.244 | -9.8 | -5.404 | -7.605 | -13.438 | -16.216 | -0.744 | -0.311 | -0.582 | -0.365 | -0.425 | -0.121 | -0.126 | -0.072 | 0.423 | 0.019 | -0.069 | -0.199 | 0.141 | -0.217 |
EBITDA Ratio
| -6.142 | -75.619 | -107.816 | -41.109 | -20.76 | -17.658 | -42.254 | -44.241 | -10.262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,588.942 | -146.59 | 831.994 | 30,108.989 | -1 | -3 | 2 | -3 |